Biosynth

No rating available

Biosynth provides custom peptide synthesis services ranging from small-scale research projects to large-scale commercial manufacturing, serving researchers, pharmaceutical companies, and vaccine developers. The company offers specialized services including neoantigen peptide production for personalized cancer treatments, GMP-compliant manufacturing, drug discovery support, and bioconjugate production. Biosynth operates as a consolidated entity combining expertise from vivitide, Pepscan, Cambridge Research Biochemicals, and Pepceuticals, with facilities across multiple locations and capabilities for complex, labeled, and difficult-to-synthesize peptides.